Expression of Epstein-Barr virus encoded nuclear antigen 1 in benign and malignant tissues harbouring EBV

Journal of Clinical Pathology

Volumn 49, Issue 11, 1996, Pages 897-902

  Oudejans, J J ^a   Dukers, D F ^a   Jiwa, N M ^a   Van Den Brule, A J C ^a   Grasser F A ^b   De Bruin, P C ^a   Horstman, A ^a   Vos, W ^a   Van Gorp, J ^c   Middeldorp, J M ^d   Meijer, C J L M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SAARLAND UNIVERSITY   (Germany)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d Organon Teknika   (Netherlands)

Author keywords

EBNA1, lymphoma; Epstein Barr virus

Indexed keywords

ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 10544240366     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.49.11.897     Document Type: Article

References (44)

1. Miller G. Epstein-Barr virus, biology, pathogenesis and medical aspects. In: Fields BN, Knipe DM, eds. Virology New York: Raven Press, 1900:1921-57.
2. Raab-Traub N. Epstein-Barr virus and nasopharyngeal carcinoma. Semin Cancer Biol 1992;3:297-307.
3. Young L, Alfieri C, Hennessy K, Evans H, O'Hara C, Anderson KC, et al. Expression of Epstein-Barr virus transformation associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med 1989;321: 1080-5.
4. Hamilton-Dutoit SJ, Pallesen G, Franzmann MB, Karkov J, Black F, Skinhoj P, et al. AIDS-related lymphoma. Histopathology, immunophenotype and association with Epstein-Barr virus as demonstrated by in-situ nucleic acid hybridisation. Am J Pathol 1991;138:149-63.
5. Howe JG, Steitz JA. Localization of Epstein-Barr virus-encoded small RNAs by in situ hybridization. Proc Natl Acad Sci USA 1984;83:9006-10.
6. Weiss LM, Movahed LA, Warnke RA, Sklar J. Detection of Epstein-Barr viral genomes in Reed Sternberg cells of Hodgkin's disease. N Engl J Med 1989;320:502-6.
7. De Bruin PC, Jiwa NM, van der Valk P, van Heerde P, Meijer CJLM. Detection of Epstein-Barr virus nucleic acid sequences and protein in nodal T-cell lymphomas: Relation between latent membrane protein 1 positivity and clinical course. Histopathology 1993;23:509-18.
8. De Bruin PC, Jiwa NM, Oudejans JJ, van der Valk P, van Heerde P, Sabourin J, et al. Presence of Epstein-Barr virus in extranodal T-cell lymphomas: differences in relation to site. Blood 1994;83:1612-18.
9. Korbjuhn P, Anagnostopoulos I, Hummel M, Tremann M, Dallenbach F, Parwaresch MR, et al. Frequent latent Epstein-Barr virus infection of neoplastic T cells and bystander B cells in human immunodeficiency virus negative European peripheral pleomorphic T-cell lymphomas. Blood 1993;82:217-23.
10. Hamilton-Dutoit SJ, Pallesen G. Detection of Epstein-Barr virus small RNAs in routine paraffin sections using non-isotopic RNA/RNA in situ hybridization. Histopathology 1994;25:101-11.
11. Hummel M, Anagnostopoulos I, Korbjuhn P, Stein H. Epstein-Barr virus in B-cell non-Hodgkin's lymphomas: Unexpected infection patterns and different infection incidence in low and high-grade types. J Pathol 1995;175:263-71.
12. Middleton T, Gahn TA, Martin JM, Sugden B. Immortalizing genes of Epstein-Barr virus. Adv Virus Res 1991;40:19-55.
13. Kaye KM, Izumi KM, Kieff E. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc Natl Acad Sci USA 1993;90:9150-4.
14. Herbst H, Dallenbach F, Hummel M, Niedobitek G, Pileri S, Mueller-Lantzsch N, et al. Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. Proc Natl Acad Sci USA 1991;88:4766-70.
15. Brooks L, Yao QY, Rickinson AB, Young LS. Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: co-expression of EBNA1, LMP1, and LMP2 transcripts. J Virol 1992;66:2689-97.
16. Deacon EM, Pallesen G, Nieboditek G, Crocker J, Brooks L, Rickinson AB, et al. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells. J Exp Med 1993;177:339-49.
17. Chen C, Sadler RH, Walling DM, Su IH, Hsieh H, Raab-Traub N. Epstein-Barr virus (EBV) gene expression in EBV-positive peripheral T-cell lymphomas. J Virol 1993; 67:6303-8.
18. Rca D, Fourcade C, Leblond V, Rowe M, Joab I, Edelman L, et al Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation. Transplantation 1994;58:317-24.
19. Gratama JW, Zutter MM, Minarovits J, Oosterveer MA, Thomas ED, Klein G, et al. Expression of Epstein-Barr virus-encoded growth-transformation-associated proteins in lymphoproliferations of bone-marrow transplant recipients. Im J Cancer 1991;47:188-92.
20. Thomas JA, Hotchin NA, Allday MJ, Amiot P, Rose M, Jacoub M, et al. Immunohistology of Epstein-Barr virus-associated antigens in B-cell disorders from immunocompromised individuals. Transplantation 1990;49:944-53.
21. Magrath I, Jain V, Bhatia K. Molecular epidemiology of Burkitt's lymphoma. In: Pagano J, Rickinson AB, eds. The Epstein-Barr virus and associated diseases. New York, CSHL Press, 1994:377.
22. Wilson JB, Levine AJ. The oncogenic potential of Epstein-Barr virus nuclear antigen-1 in transgenic mice. Curr Top Microbiol Immunol 1992;182:374-84.
23. Srinivas SK, Sixbey J. Epstein-Barr virus induction of recombinase-activating genes RAG1 and RAG2. J Virol 1995;69:8155-8.
24. Sample J, Brooks L, Sample C, Young L, Rowe M, Gregory C, et al. Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site. Proc Natl Acad Sci USA 1991;88:6343-47.
25. Schaefer BC, Strominger JL, Speck SH. The Epstein-Barr virus BamHI F promoter is an early lytic promoter: Lack of correlation with EBNA1 gene transcription in group 1 Burkitt's lymphoma cell lines. J Virol 1995;69:5039-47.
26. Lear AL, Rowe M,1 Kurilla MG, Lee S, Henderson S, Kieff E, et al. The Epstein-Barr virus (EBV) nuclear antigen 1 Bam HI F promoter is activated on entry of EBV transformed B-cells into the lytic cycle. J Virol 1992;66; 7461-8.
27. Grässer FA, Murray PG, Kremmer E, Klein K, Remberger K, Feiden W, et al. Monoclonal antibodies directed against the Epstein-Barr virus-encoded nuclear antigen 1 (EBNA1): Immunohistologic detection of EBNA1 in the malignant cells of Hodgkin's disease. Blood 1994;84:3792-8.
28. Jiwa NM, Kanavaros P, De Bruin PC, van der Valk P, Horstman A, Vos W, et al. Presence of Epstein-Barr virus harbouring small and intermediate-sized cells in Hodgkin's disease. Is there a relationship with Reed-Sternberg cells? J Pathol 1993;170:129-36.
29. Oudejans JJ, Jiwa NM, van den Brule AJC, Grässer FA, Horstman A, Vos W, et al. Detection of heterogeneous Epstein-Barr virus gene expression patterns within individual post-transplantation lymphoproliferative disorders. Am J Pathol 1995;147:923-33.
30. Stansfeld AG, Diebold D, Kapanci Y, Kelenyi G, Lennert K, Mioduszewska O, et al. Updated Kiel classification of non-Hodgkin's lymphomas. Lancet 1988;i:292-3.
31. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, et al. A revised European-American classification of lymphoid neoplasms: A proposal from the international lymphoma study group. Blood 1994;84:1361-92.
32. Frizzera G, Hanto DW, Gajl-Peczalska KJ, Rosa J, McKenna R, Sibley R, et al. Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients, Cancer Res 1981;41:4262-79.
33. Knowles DM, Cesarman E, Chadburn A, Frizzera G, Chen J, Rose EA, et al. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Biood 1995;85:552-65.
34. Lukes RJ, Craver LF, Hall TC, Rappaport H, Ruben P. Report of the nomenclature committee. Cancer Res 1966;26:1310-11.
35. Bobrow MN, Shaughnessy KJ, Litt GJ Catalyzed reporter deposition, a novel method of signal amplification. II. Application to membrane immunoassays. J Immunol Methods 1991;137:103-12.
36. Weiss LM, Jaffe ES, Liu X-F, Chen Y-Y, Shibata D, Medeiros LJ. Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Blood 1992;79:1789-95.
37. Bijl J, van Oostveen JW, Krieke M, Rieger H, van der Raaij-Helmer L, Walboomers JMM, et al. Expression of HOXC4, -C5 and -C6 in human lymphoid cell lines, leukemias and in benign and malignant lymphoid tissue. Blood 1996;87: 1737-45.
38. Brooks IA, Lear AL, Young LS, Rickinson AB. Transcripts from the Epstein-Barr virus BamHI A fragment are detectable in all three forms of virus latency. J Virol 1993;67: 3182-90.
39. Oudejans JJ, van den Brule AJC, Jiwa NM, de Bruin PC, Ossenkoppele GJ, van der Valk P, et al. BHRF1, the Epstein-Barr virus (EBV) homologue of the bcl-2 (proto-) oncogene is transcribed in EBV associated B-cell lymphomas and in reactive lymphocytes. Blood 1995;86:1893-902.
40. Chen F, Zou J, di Renzo L, Winberg G, Hu I, Klein E, et al. A subpopulation of normal B cells latently infected with Epstein-Barr virus resembling Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP-1. J Virol 1995;69:3752-8.
41. Tierney, RJ, Steven N, Young LS, Rickinson AB. Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. J Virol 1994;68:7374-85.
42. Jiwa NM, Oudejans JJ, Dukers DF, Vos W, Horstman A, van der Valk P, et al. Immunohistochemical demonstration of different latent membrane protein-1 epitopes of Epstein-Barr virus in lymphoproliferative diseases. J Clin Pathol 1995;48:438-42.
43. Khan G, Naase MA. Down-regulation of Epstein-Barr virus nuclear antigen 1 in Reed-Sternberg cells of Hodgkin's disease. J Clin Pathol 1995;48:845-8.
44. Kaplan LD, Shiramizu B, Herndier B, Hahn J, Meeker TC, Ng V, et al. Influence of molecular characteristics on clinical outcome in human immunodeficiency virus-associated non-Hodgkin's lymphoma: identification of a subgroup with favorable clinical outcome. Blood 1995;85:1727-35.